Activated microglia mitigate Aβ-associated tau seeding and spreading

• Published in: The Journal of experimental medicine Vol. 218; no. 8
• Main Authors: Gratuze, Maud, Chen, Yun, Parhizkar, Samira, Jain, Nimansha, Strickland, Michael R., Serrano, Javier Remolina, Colonna, Marco, Ulrich, Jason D., Holtzman, David M.
• Format: Journal Article
• Language: English
• Published: United States Rockefeller University Press 02.08.2021
• Subjects: Amyloid beta-Peptides - metabolism; Animals; Apolipoproteins E - metabolism; Brief Definitive Report; Homeostasis; Life Sciences; Macrophages - metabolism; Membrane Glycoproteins - deficiency; Membrane Glycoproteins - metabolism; Mice, Knockout; Microglia - metabolism; Neurites - metabolism; Neurites - pathology; Neuroinflammation; Phenotype; Plaque, Amyloid - pathology; Receptors, Immunologic - deficiency; Receptors, Immunologic - metabolism; tau Proteins - metabolism
• ISSN: 0022-1007; 1540-9538; 1540-9538
• DOI: 10.1084/jem.20210542

In Alzheimer’s disease (AD) models, AD risk variants in the microglial-expressed TREM2 gene decrease Aβ plaque–associated microgliosis and increase neuritic dystrophy as well as plaque-associated seeding and spreading of tau aggregates. Whether this Aβ-enhanced tau seeding/spreading is due to loss of microglial function or a toxic gain of function in TREM2-deficient microglia is unclear. Depletion of microglia in mice with established brain amyloid has no effect on amyloid but results in less spine and neuronal loss. Microglial repopulation in aged mice improved cognitive and neuronal deficits. In the context of AD pathology, we asked whether microglial removal and repopulation decreased Aβ-driven tau seeding and spreading. We show that both TREM2KO and microglial ablation dramatically enhance tau seeding and spreading around plaques. Interestingly, although repopulated microglia clustered around plaques, they had a reduction in disease-associated microglia (DAM) gene expression and elevated tau seeding/spreading. Together, these data suggest that TREM2-dependent activation of the DAM phenotype is essential in delaying Aβ-induced pathological tau propagation.